 |
|
|
| |
Safety and Efficacy of Combination Therapies Including Cilofexor/Firsocostat in Patients With Bridging Fibrosis and Cirrhosis Due to NASH: Results of the Phase 2b ATLAS Trial
|
| |
| |
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Rohit Loomba,1Mazen Noureddin,2Kris V. Kowdley,3 Anita Kohli,4 Aasim Sheikh,5Guy Neff,6 Bal Raj Bhandari,7 NadegeGunn,8Stephen H. Caldwell,9Zachary Goodman,10Ilan Wapinski,11Murray Resnick,11Andrew H. Beck,11Dora Ding,12Catherine Jia,12 Ryan S. Huss,12Chuhan Chung,12 G. Mani Subramanian,12 Robert P. Myers,12Keyur Patel,13Brian B. Borg,14Reem Ghalib,15Heidi Kabler,16John Poulos,17Ziad Younes,18Magdy Elkhashab,19Tarek Hassanein,20Rajalakshmi Iyer,21Peter J Ruane,22Mitchell L. Shiffman,23Simone Strasser,24Vincent Wai-Sun Wong,25 NaimAlkhouri,26for the ATLAS Investigators
1University of California at San Diego, La Jolla, CA, USA; 2Cedars-Sinai Medical Center, Los Angeles, CA, USA; 3Liver Institute Northwest, Washington State University, Seattle, WA, USA; 4Arizona Liver Health, Chandler, AZ, USA; 5Gastrointestinal Associates of Georgia, Marietta, GA, USA; 6Covenant Research, Sarasota, FL, USA; 7Delta Research Partners, Monroe, LA, USA; 8Pinnacle Clinical Research, San Antonio, TX, USA; 9University of Virginia, Charlottesville, VA, USA; 10Inova Fairfax Hospital, Falls Church, VA, USA; 11PathAI, Boston, MA, USA; 12Gilead Sciences, Inc., Foster City, CA, USA; 13University of Toronto, Toronto, ON, Canada; 14Southern Therapy and Advance Research, Jackson, MS, USA; 15Texas Clinical Research, Arlington, TX, USA; 16Jubilee Clinical Research, Las Vegas, NV, USA; 17Cumberland Research Associates, Fayetteville, NC, USA; 18Gastro One, Germantown, TN, USA; 19Toronto Liver Centre, Toronto, ON, Canada; 20Southern California Liver Centers, Coronado, CA, USA; 21Iowa Digestive Disease Center, Clive, IA, USA; 22Ruane Medical and Liver Health Institute, Los Angeles, CA, USA; 23Bon Secours Mercy Health, Richmond, VA, USA; 24Royal Prince Alfred Hospital, AW Morrow Gastroenterology and Liver Centre, University of Sydney, NSW, Australia; 25The Chinese University of Hong Kong, Hong Kong; 26Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, USA
|
| |
|
|
|
|
|
